Table 2.
Correlation expressed by r-value and its significance between analyzed biochemical indices and TGF-β1, TIMP-1 or MMP-1 in chronic hepatitis B patients treated with lamivudine
| mean ± SE | TGF-β1 | TIMP-1 | MMP-1 | |
| Bil (mg%) | 1.02 ± 0.06 | 0.049 | 0.119 | -0.059 |
| ALT (U/L) | 74.50 ± 5.9 | 0.201a | 0.247a | 0.005 |
| AST (U/L) | 60.10 ± 5.2 | 0.244a | 0.269a | -0.029 |
| ALP (U/L) | 96.10 ± 3.8 | 0.114 | 0.295a | -0.071 |
| GGT (U/L) | 47.70 ± 4.9 | 0.062 | 0.247a | -0.102 |
| PI (%) | 87.30 ± 1.5 | -0.109 | 0.006 | -0.065 |
Bil: bilirubin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: gamma glutamyltranspeptidase; PI: prothrombin index.
a
P < 0.05 vs other groups.